Abstract
The DIAS system utilizes a control to range-based algorithm for glucose control in type 1 diabetes. The system includes a Dexcom G4 sensor, a Roche AccuCheck pump and an Android-based DIAS controller. The objective of this study was to test the safety and efficacy of DIAS in subjects with type 1 diabetes, aged 10-35 y, over 5 days at diabetes camp. There were 33 subjects randomized to either closed-loop with DIAS (intervention) or sensor-augmented pump (control) for 5 days at diabetes camp. Both groups utilized premeal boluses.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call